Biocon Ltd

NSE: BIOCON · BSE: 532523 · Pharmaceuticals & Biotechnology · 57 announcements

Biocon Ltd news stories on ALFA NewsRead the news →

Share price: ₹360.70
Market cap: ₹58,783 Cr
Revenue (annual): ₹16,927 Cr
Net profit (annual): ₹385.6 Cr
P/E (TTM): 118.7×Sector 47.4×
Promoter holding: 44.68%-0.23% QoQ
FII holding: 8.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

29 Jun 2026 22:33 IST BSE

Biocon Merger & Restructuring Worth ₹330.7 Cr

Biocon Limited acquired remaining stakes in Biocon Biologics via a Rs. 330.73 Crore share swap. BBL is now a wholly-owned subsidiary after 87.86 lakh shares were allotted.

Value: ₹330.7 Cr

Read the filing ↗

8 May 2026 20:25 IST NSE

Merger & Restructuring

Biocon Merger & Restructuring Worth ₹473.4 Cr

Biocon Limited will acquire 1.06 crore equity shares in Biocon Biologics via CCD conversion worth ₹473.40 Crore. The move aims to simplify its corporate structure.

Value: ₹473.4 Cr

Read the filing ↗